Davinthra Thillainathan
Stock Analyst at Goldman Sachs
(1.68)
# 3,567
Out of 4,683 analysts
36
Total ratings
40.9%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Davinthra Thillainathan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ACL Australian Clinical Labs Limited | Downgraded: Sell | $3.30 → $2.08 | $2.83 | -26.37% | 2 | Aug 6, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Upgraded: Hold | $2.10 → $2.15 | $2.31 | -6.93% | 2 | Jun 1, 2026 | |
| ASX: ANN Ansell Limited | Initiated Coverage: Hold | $31.80 | $40.18 | -20.85% | 1 | Apr 7, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $51.55 → $53.11 | $44.14 | +20.33% | 5 | Feb 23, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $49.30 → $53.20 | $32.53 | +63.54% | 9 | Feb 2, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $304.60 → $212.10 | $173.10 | +22.53% | 5 | Oct 29, 2025 | |
| ASX: NAN Nanosonics Limited | Initiated Coverage: Buy | $6.83 | $2.78 | +145.63% | 1 | Sep 25, 2025 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | n/a | $50.60 | - | 4 | Sep 11, 2025 | |
| ASX: HLS Healius Limited | Maintained: Sell | $1.20 → $0.80 | $0.44 | n/a | 2 | Aug 12, 2025 | |
| ASX: COH Cochlear Limited | Maintained: Hold | n/a | $135.98 | n/a | 4 | Jun 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32.20 | $20.24 | n/a | 1 | Apr 3, 2025 |
Australian Clinical Labs Limited
Aug 6, 2026
Downgraded: Sell
Price Target: $3.30 → $2.08
Current: $2.83
Upside: -26.37%
Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10 → $2.15
Current: $2.31
Upside: -6.93%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $40.18
Upside: -20.85%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Maintained: Buy
Price Target: $51.55 → $53.11
Current: $44.14
Upside: +20.33%
ResMed Inc.
Feb 2, 2026
Maintained: Buy
Price Target: $49.30 → $53.20
Current: $32.53
Upside: +63.54%
CSL Limited
Oct 29, 2025
Maintained: Buy
Price Target: $304.60 → $212.10
Current: $173.10
Upside: +22.53%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $6.83
Current: $2.78
Upside: +145.63%
Ramsay Health Care Limited
Sep 11, 2025
Maintained: Hold
Price Target: n/a
Current: $50.60
Upside: -
Healius Limited
Aug 12, 2025
Maintained: Sell
Price Target: $1.20 → $0.80
Current: $0.44
Upside: n/a
Cochlear Limited
Jun 14, 2025
Maintained: Hold
Price Target: n/a
Current: $135.98
Upside: n/a
Apr 3, 2025
Initiated Coverage: Buy
Price Target: $32.20
Current: $20.24
Upside: n/a